Skip to main content

Advertisement

SpringerLink
Log in

CD28, CTLA-4 and CCL5 gene polymorphisms in patients with rheumatoid arthritis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint destruction caused by infiltrating leukocytes including T cells. An important role in T cell co-stimulation is played by the CD28, as a stimulatory signal transducer and the inhibitory CTLA-4. CCL5 is produced by circulating T cells and plays an active role in the chemotactic activity of T cells in RA. The aim of this study was to examine the associations between polymorphisms within CD28, CTLA-4, and CCL5 genes and RA. We examined 422 patients (340 female, 82 male, mean age 57.5 ± 12.5 years) with rheumatoid arthritis and 338 healthy subjects (261 female, 77 male). Disease activity was determined on the basis of DAS28 score. The patients with DAS28 of ≤2.5 were classified as subjects in remission of disease symptoms; the patients who had DAS28 of >2.5 were classified as subjects with active form of RA. There were no statistically significant differences in the distribution of studied genotypes and alleles between RA patients and the control group. A statistically significant difference was observed in the distribution of CTLA4 exon 1 +49A>G rs231775 genotypes between patients with DAS28 ≤ 2.5 and DAS28 > 2.5 where the increased frequency of AA genotype among patients with DAS28 > 2.5 was revealed (OR 1.55; 95% CI 1.01–2.38). The results of our study suggest no significant association between CD28 rs1980422, CCL5 rs2107538, CTLA-4 exon 1 +49A>G rs231775 and rs3087243 gene polymorphisms and RA in the Polish population. Our results indicate a possible association between CTLA-4 exon 1 +49A>G rs231775 gene polymorphism and RA activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brunner MC (1999) Costimulatory molecules and modulation. Immunologist 7:9–12

    Google Scholar 

  2. Borriello F, Sethna MP, Boyd SD, Schweitzer AN, Tivol EA, Jacoby D, Strom TB, Simpson EM, Freeman GJ, Sharpe AH (1997) B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6:303–313

    Article  CAS  PubMed  Google Scholar 

  3. Schwartz JC, Zhang X, Fedorov AA, Nathenson SG, Almo SC (2001) Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Nature 410:604–608

    Article  CAS  PubMed  Google Scholar 

  4. Yoshida S, Arakawa F, Higuchi F, Ishibashi Y, Goto M, Sugita Y, Nomura Y, Niino D, Shimizu K, Aoki R, Hashikawa K, Kimura Y, Yasuda K, Tashiro K, Kuhara S, Nagata K, Ohshima K (2012) Gene expression analysis of rheumatoid arthritis synovial lining regions by cDNA microarray combined with laser microdissection: up-regulation of inflammation-associated STAT1, IRF1, CXCL9, CXCL10, and CCL5. Scand J Rheumatol 41(3):170–179

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Aletaha D, Neogi T, Silman AJ et al (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–25681

    Article  PubMed  Google Scholar 

  6. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, Furst D et al (1993) The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 36:729–740

    Article  CAS  PubMed  Google Scholar 

  7. Humphreys JH, Symmons DP (2012) Post publication validation of the 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: where do we stand? Curr. Opin. Rheumatol

  8. Chambers CA, Sullivan TJ, Truong T, Allison JP (1998) Secondary but not primary T cell responses are enhanced in CTLA-4-deficient CD8+ T cells. Eur J Immunol 28:3137–3143

    Article  CAS  PubMed  Google Scholar 

  9. Riley JL, Mao M, Kobayashi S, Biery M, Burchard J, Cavet G, Gregson BP, June CH, Linsley PS (2002) Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc Natl Acad Sci U S A 99:11790–11795

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Yao TC, Kuo ML, See LC, Ou LS, Lee WI, Chan CK, Huang JL (2006) RANTES and monocyte chemoattractant protein 1 as sensitive markers of disease activity in patients with juvenile rheumatoid arthritis: a six-year longitudinal study. Arthritis Rheum 54(8):2585–2593

    Article  CAS  PubMed  Google Scholar 

  11. Raychaudhuri S, Thomson BP, Remmers EF, Eyre S, Hinks A, Guiducci C, Catanese JJ, Xie G, Stahl EA (2009) Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet 41(12):1313–1318

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kim YO, Kim HJ, Kim SK, Chung JH, Hong SJ (2010) Association of the CD28/CTLA4/ICOS polymorphisms with susceptibility to rheumatoid arthritis. Clin Chem Lab Med 48(3):345–353. doi:10.1515/CCLM.2010.074

    Article  CAS  PubMed  Google Scholar 

  13. Ledezma-Lozano IY, Padilla-Martínez JJ, Leyva-Torres SD, Parra-Rojas I, Ramírez-Dueñas MG, Pereira-Suárez AL (2011) Association of CD28 IVS3+17T/C polymorphism with soluble CD28 in rheumatoid arthritis. Dis Markers 30(1):25–29. doi:10.3233/DMA-2011-0760

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Prasad P, Kumar A, Gupta R, Juyal RC, Thelma BK (2012) Caucasian and Asian specific rheumatoid arthritis risk loci reveal limited replication and apparent allelic heterogeneity in north Indians. PLoS One 7(2):e31584. doi:10.1371/journal.pone.0031584

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Lee SH, Lee EB, Shin ES, Lee JE, Cho SH, Min KU, Park HW (2014) The interaction between allelic variants of CD86 and CD40LG: a common risk factor of allergic asthma and rheumatoid arthritis. Allergy Asthma Immunol Res 6(2):137–141

    Article  PubMed  Google Scholar 

  16. Wang CR, Guo HR, Liu MF (2005) RANTES promoter polymorphism as a genetic risk factor for rheumatoid arthritis in the Chinese. Clin Exp Rheumatol 23(3):379–384

    CAS  PubMed  Google Scholar 

  17. Pavkova Goldbergova M, Lipkova J, Pavek N, Gatterova J, Vasku A, Soucek M, Nemec P (2012) RANTES, MCP-1 chemokines and factors describing rheumatoid arthritis. Mol Immunol 52(3–4):273–278

    Article  CAS  PubMed  Google Scholar 

  18. Wen D, Du X, Qiao Y, Dong JZ, Ma CS (2015) RANTES gene polymorphisms are not associated with rheumatoid arthritis and atopic dermatitis: a meta-analysis. Int Rev Immunol 34(6):500–508

    Article  CAS  PubMed  Google Scholar 

  19. Han S, Li Y, Mao Y, Xie Y (2005) Meta-analysis of the association of CTLA-4 exon-1 +49A/G polymorphism with rheumatoid arthritis. Hum Genet 118(1):123–132

    Article  CAS  PubMed  Google Scholar 

  20. Li G, Shi F, Liu J, Li Y (2014) The effect of CTLA-4 A49G polymorphism on rheumatoid arthritis risk: a meta-analysis. Diagn Pathol 9:157. doi:10.1186/s13000-014-0157-0

    Article  PubMed  PubMed Central  Google Scholar 

  21. Li X, Zhang C, Zhang J, Zhang Y, Wu Z, Yang L, Xiang Z, Qi Z, Zhang X, Xiao X (2012) Polymorphisms in the CTLA-4 gene and rheumatoid arthritis susceptibility: a meta-analysis. J Clin Immunol 32(3):530–539

    Article  PubMed  Google Scholar 

  22. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G et al (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506–511

    Article  CAS  PubMed  Google Scholar 

  23. Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ (2000) CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves’ disease. J Immunol 165:6606–6611

    Article  CAS  PubMed  Google Scholar 

  24. Tang MJ, Zhou ZB (2013) Association of the CTLA-4 +49A/G polymorphism with rheumatoid arthritis in Chinese Han population. Mol Biol Rep 40(3):2627–2631

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physiology, Pomeranian Medical University, Powstancow Wlkp. 72, 70-111, Szczecin, Poland

    Katarzyna Luterek-Puszyńska, Damian Malinowski & Andrzej Pawlik

  2. Department of Experimental and Clinical Pharmacology, Pomeranian Medical University, Szczecin, Poland

    Damian Malinowski

  3. Department of Biochemistry and Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland

    Agnieszka Paradowska-Gorycka

  4. Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, Szczecin, Poland

    Krzysztof Safranow

Authors
  1. Katarzyna Luterek-Puszyńska
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Damian Malinowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Agnieszka Paradowska-Gorycka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Krzysztof Safranow
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andrzej Pawlik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrzej Pawlik.

Ethics declarations

The study was approved by the ethics committee of Pomeranian Medical University, Szczecin, Poland, and written informed consent was obtained from all subjects.

Disclosures

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Luterek-Puszyńska, K., Malinowski, D., Paradowska-Gorycka, A. et al. CD28, CTLA-4 and CCL5 gene polymorphisms in patients with rheumatoid arthritis. Clin Rheumatol 36, 1129–1135 (2017). https://doi.org/10.1007/s10067-016-3496-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-016-3496-2

Keywords

Search

Navigation